Study: Ishack 2022, International Journal of Dermatology

Exogenous ochronosis associated with hydroquinone: a systematic review

Citation

Ishack S, Lipner SR (2022). International Journal of Dermatology. PubMed id 34486734.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Skin lightening and bleaching creams Tier B moderate

    B 126 patients with hydroquinone-associated ochronosis in 56 case reports (n=126)

    Systematic review of case reports.

    Of cases, 55.5% were reported as Black and 52.4% were Fitzpatrick V-VI. Median use was 5 years; four cases came after 3 months or less and eight after a year or less. Concentrations above 4% were most often implicated. All had blue-black or grey-blue lace-like marks on the face; treatment is often unsatisfactory.

    As recorded in this card: Ishack S, Lipner SR (2022), International Journal of Dermatology, [review]

    Note: Case reports cannot give a risk rate; they show the harm exists and who it is reported in.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.